XBIO (STOCKS)
Xenetic Biosciences, Inc.
$3.200000
+0.000000 (+0.00%)
Prev close: $3.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- James F. Parslow
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.41M
- Employees
- 2
- P/E (TTM)
- -2.64
- P/B (TTM)
- 1.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2025 (Q2)
|
$-0.45 | $-0.65 | +0.2028 | +31.07% |
|
Mar 2025 (Q1)
|
$-0.59 | $-0.73 | +0.1444 | +19.66% |
|
Dec 2024 (Q4)
|
$-0.68 | $-0.20 | -0.4760 | -233.33% |
|
Sep 2024 (Q3)
|
$-0.28 | $-0.14 | -0.1372 | -96.08% |
Financial Statements
| Revenues | $3.19M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $5.58M |
| Nonoperating Income/Loss | $160.19K |
| Operating Expenses | $5.58M |
| Research and Development | $2.85M |
| Other Operating Expenses | $2.74M |
| Operating Income/Loss | -$2.39M |
| Income/Loss From Continuing Operations After Tax | -$2.23M |
| Income/Loss From Continuing Operations Before Tax | $3.19M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$2.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.20 |
| Diluted Earnings Per Share | -$1.20 |
| Basic Average Shares | 5,534,766 |
| Diluted Average Shares | 5,534,766 |
| Assets | $7.91M |
| Current Assets | $7.60M |
| Noncurrent Assets | $313.92K |
| Liabilities | $958.24K |
| Current Liabilities | $958.24K |
| Accounts Payable | $558.81K |
| Other Current Liabilities | $399.43K |
| Noncurrent Liabilities | $0.00 |
| Equity | $6.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.95M |
| Liabilities And Equity | $7.91M |
| Net Cash Flow From Operating Activities | -$1.82M |
| Net Cash Flow From Operating Activities, Continuing | -$1.82M |
| Net Cash Flow | $465.52K |
| Net Cash Flow, Continuing | $465.52K |
| Comprehensive Income/Loss | -$2.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.23M |
| Other Comprehensive Income/Loss | $0.00 |